ECS submits plans for major expansion in Tasmania
• ECS has submitted plans to the Office of Drug and signed leases with farmers to expand cultivation at its Tasmanian operation by 100 times its current area
• Expansion lays foundation to become a global leader in regulated medicinal cannabis production and distribution of active pharmaceutical ingredients (API’s)
• ECS establishing a large scale, low-cost cultivation and processing model - similar to the world leading Tasmanian opium sector